| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.0096 | 1 |